Global patent index - EP 1034256 A1

EP 1034256 A1 2000-09-13 - ANTICOAGULANT TEST

Title (en)

ANTICOAGULANT TEST

Title (de)

ANTIKOAGULANS TEST

Title (fr)

TEST ANTICOAGULANT

Publication

EP 1034256 A1 (EN)

Application

EP 98953452 A

Priority

  • GB 9806037 A
  • US 9821596 W
  • US 6183997 P

Abstract (en)

[origin: WO9919463A1] The present invention is a method for diagnosing a patient at risk to thrombocytopenia induced by administration of a GP IIb/IIIa receptor antagonist, which comprises combining i) a plasma sample of the patient; ii) detectable monoclonal antibody which recognizes induced binding sites formed on the GP IIb/IIIa receptor following association of a fibrinogen receptor antagonist with the GP IIb/IIIa receptor; and iii) GP IIb/III a receptor: GP IIb/III receptor antagonist complex, and determining association of the detectable monoclonal antibody with the complex in the presence of the plasma.

IPC 1-7 (main, further and additional classification)

C12N 5/12; C07K 16/00; G01N 33/53

IPC 8 full level (invention and additional information)

C07K 16/28 (2006.01); G01N 33/68 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C07K 16/2848 (2013.01); G01N 33/68 (2013.01); A61K 38/00 (2013.01); C07K 2317/24 (2013.01); G01N 2333/70557 (2013.01); G01N 2800/222 (2013.01); G01N 2800/224 (2013.01)

Citation (search report)

See references of WO 9919463A1

Designated contracting state (EPC)

AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

EPO simple patent family

WO 9919463 A1 19990422; AU 1082699 A 19990503; CA 2308122 A1 19990422; EP 1034256 A1 20000913

INPADOC legal status

2003-11-19 [18W] WITHDRAWN

- Ref Legal Event Code: 18W

- Effective date: 20030925

2000-09-13 [17P] REQUEST FOR EXAMINATION FILED

- Ref Legal Event Code: 17P

- Effective date: 20000515

2000-09-13 [AK] DESIGNATED CONTRACTING STATES:

- Ref Legal Event Code: AK

- Designated State(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE